Financial relationships with industry among national comprehensive cancer network guideline authors

JAMA Oncology

Volumn 2, Issue 12, 2016, Pages 1660-

  Carlson, Robert W ^a,b   McClure, Joan S ^c  

^a National Comprehensive Cancer Network   (United States)

^b FOX CHASE CANCER CENTER   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONFLICT OF INTEREST; DRUG INDUSTRY; ECONOMICS; HUMAN; NEOPLASMS; PROTOCOL COMPLIANCE; UNITED STATES;

CONFLICT OF INTEREST; DRUG INDUSTRY; GUIDELINE ADHERENCE; HUMANS; NEOPLASMS; UNITED STATES;

EID: 85013149455     PISSN: 23742437     EISSN: 23742445     Source Type: Journal    
DOI: 10.1001/jamaoncol.2016.4919     Document Type: Letter

References (3)

1. Mitchell AP, Basch EM, Dusetzina SB. Financial relationships with industry among National Comprehensive Cancer Network Guideline authors [published online August 25, 2016]. JAMA Oncol. doi:10.1001/jamaoncol.2016.2710
2. NCCN Disclosure Policies and Potential Conflicts of Interest. https://www.nccn .org/about/disclosure.aspx. Accessed September 9, 2016.
3. Nipp RD,Moy B. No conflict, no interest [published online August 25, 2016]. JAMA Oncol. doi:10.1001/jamaoncol.2016.2726